PHARMA
There's nothing generic about our Hatch Waxman expertise.
Intrepid’s Managed Review solution places a significant emphasis on the Pharmaceutical Sector, particularly legal cases arising from the Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act. Our tenured team possesses substantial knowledge, expertise and deep understanding of the crucial elements within the pharmaceutical field having completed multiple matters for our clients, hence reducing / eliminating the need for training and clarity.
Expertise in PIII, PIV, & More.
30%
Our reviews are typically about thirty percent more efficient.
40+
To be on the team, reviewers need 40 reviews under their belt. Most have closer to 100.
6yrs
Our review managers have over six years of dedicated Pharma expertise.
HATCH WAXMAN FOCUS AND EXPERTISE
A proven, reliable team
Leveraging our extensive technical expertise, Intrepid’s Hatch Waxman managed document review teams have a rich history completing matters within short timeframes and limited budgets, typically yielding results 30% lower than industry standard costs.
- We reliably retain our proven attorneys and maintain a team culture
- We encourage creative collaboration for insights
- Minimal training or explanations needed due to experienced team
- We constantly leverage our extensive industry experience
- We use metrics and data to inform and drive decision making
- Multilingual review teams available at a moments notice
ALL areas of expertise
- Paragraph III
- Paragraph IV
- FTF
- FTM
- NDA
- ANDA
- API
“From top leadership to hands-on execution, the Intrepid team possesses a powerful blend of pharma matter expertise and grit to get the job done, resulting in flawless final production on every project we’ve collaborated on.”
